2017 | 18F-AV-1451 Binds to Putamen in Multiple System Atrophy | MOVEMENT DISORDERS |
2010 | A case-control study of multiple system atrophy in Korean patients | MOVEMENT DISORDERS |
2010 | A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry | MOVEMENT DISORDERS |
2007 | Abnormal temporal discrimination threshold in patients with multiple system atrophy | MOVEMENT DISORDERS |
1998 | Abrupt onset of transient pseudochoreoathetosis associated with proprioceptive sensory loss as a result of a thalamic infarction | MOVEMENT DISORDERS |
2006 | Anatomy and physiology of the basal ganglia: Implications for deep brain stimulation for Parkinson's disease | MOVEMENT DISORDERS |
2008 | Anticholinergic-responsive gait freezing in a patient with pantothenate kinase-associated neurodegeneration | MOVEMENT DISORDERS |
2006 | Cardiac 123I-MIBG scintigraphy in patients with essential tremor | MOVEMENT DISORDERS |
2010 | Chorea induced by antihistamine drugs | MOVEMENT DISORDERS |
2006 | Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy | MOVEMENT DISORDERS |
2022 | Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study | MOVEMENT DISORDERS |
2007 | Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on Parkinsonian motor deficits and freezing of gait | MOVEMENT DISORDERS |
2023 | Differential Implications of Cerebral Hypoperfusion and Hyperperfusion in Parkinson's Disease | MOVEMENT DISORDERS |
2018 | Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases | MOVEMENT DISORDERS |
2005 | Dopaminergic influence on disturbed spatial discrimination in Parkinson's disease | MOVEMENT DISORDERS |
1994 | “Drop attacks” with stiffening of the right leg associated with posterior fossa arachnoid cyst | MOVEMENT DISORDERS |
2008 | Drug-induced and psychogenic resting suprahyoid neck and tongue tremors | MOVEMENT DISORDERS |
2023 | Effect of Amyloid on Cognitive Performance in Parkinson's Disease and Dementia with Lewy Bodies | MOVEMENT DISORDERS |
2010 | Effects of chronic subthalamic stimulation on intractable akathisia in Parkinson's disease | MOVEMENT DISORDERS |
2023 | Effects of Dihydropyridines on the Motor and Cognitive Outcomes of Patients with Parkinson's Disease | MOVEMENT DISORDERS |
2006 | Electromyography patterns of propriospinal myoclonus can be mimicked voluntarily | MOVEMENT DISORDERS |
2023 | Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort | MOVEMENT DISORDERS |
2014 | Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease: flow-mediated dilation study. | MOVEMENT DISORDERS |
2009 | Factors contributing to the development of restless legs syndrome in patients with Parkinson disease | MOVEMENT DISORDERS |
2019 | Four-year Follow-Up Results of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor | MOVEMENT DISORDERS |
2005 | Frequent sequence variation at the ETM2 locus and its association with sporadic essential tremor in Korea | MOVEMENT DISORDERS |
2019 | Gastrectomy and nigrostriatal dopaminergic depletion in de novo Parkinson's disease | MOVEMENT DISORDERS |
2009 | Giant somatosensory evoked potential in a patient with shaking TIA. | MOVEMENT DISORDERS |
2020 | Identifying the Functional Brain Network of Motor Reserve in Early Parkinson's Disease | MOVEMENT DISORDERS |
2011 | Imaging evidence of nigral damage in dystonia secondary to disulfiram intoxication | MOVEMENT DISORDERS |
2010 | Impaired finger dexterity in patients with parkinson's disease correlates with discriminative cutaneous sensory dysfunction | MOVEMENT DISORDERS |
2023 | Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers | MOVEMENT DISORDERS |
2015 | Is Dominant-Side Onset Associated With a Better Motor Compensation in Parkinson's Disease? | MOVEMENT DISORDERS |
2020 | Later-Onset Multiple System Atrophy: A Multicenter Asian Study | MOVEMENT DISORDERS |
2013 | Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons | MOVEMENT DISORDERS |
2019 | Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease | MOVEMENT DISORDERS |
2020 | Motor Cerebellar Connectivity and Future Development of Freezing of Gait in De Novo Parkinson's Disease | MOVEMENT DISORDERS |
2005 | Motor training as treatment in focal hand dystonia | MOVEMENT DISORDERS |
2010 | Movement disorders associated with moyamoya disease: a report of 4 new cases and a review of literatures | MOVEMENT DISORDERS |
2009 | Normal diffusion-weighted MR imaging predicts a good prognosis in extrapontine myelinolysis-induced parkinsonism | MOVEMENT DISORDERS |
2023 | Obstructive Sleep Apnea and Striatal Dopamine Availability in Parkinson's Disease | MOVEMENT DISORDERS |
1997 | Periodic Bursts of Rhythmic Dyskinesia Associated with Spinal Anesthesia | MOVEMENT DISORDERS |
2013 | Population-specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO-PD) consortium | MOVEMENT DISORDERS |
2010 | Primary progressive freezing gait in a patient with CO-induced parkinsonism | MOVEMENT DISORDERS |
2009 | Psychogenic paroxysmal dyskinesia: the role of placebo in the diagnosis and management | MOVEMENT DISORDERS |
2009 | Serum cholesterol levels and the risk of multiple system atrophy: a case-control study. | MOVEMENT DISORDERS |
1996 | Sleep related periodic leg movments associated with spinal cord lesion | MOVEMENT DISORDERS |
2017 | Subcortical 18 F-AV-1451 binding patterns in progressive supranuclear palsy | MOVEMENT DISORDERS |
2017 | Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease | MOVEMENT DISORDERS |
2003 | Subtraction brain SPECT imaging in a patient with gait ignition failure | MOVEMENT DISORDERS |
2007 | The contribution of a spinal mechanism in developing peripheral myoclonus: A case report | MOVEMENT DISORDERS |
2022 | The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited | MOVEMENT DISORDERS |
2011 | The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status | MOVEMENT DISORDERS |
2010 | Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. | MOVEMENT DISORDERS |
2011 | Uric acid as a potential disease modifier in patients with multiple system atrophy | MOVEMENT DISORDERS |
2021 | White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease | MOVEMENT DISORDERS |